FDA Adverse Event Injury Summary report: N

TALENT THORACIC STENT GRAFT SYSTEM

MDR report key: 1993733 · Received February 11, 2011

Report

Report Number
2953200-2011-00383
Event Type
Injury
Date Received
February 11, 2011
Date of Event
January 13, 2011
Report Date
January 13, 2011
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
MIH
PMA / PMN Number
P070007
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: (ENDOLEAK), (CAUSE OF TYPE III ENDOLEAK UNK). EVAL, CONCLUSION: (CAUSE OF TYPE III ENDOLEAK UNK).

Description of Event or Problem · 1

A TALENT STENT GRAFT SYSTEM WAS IMPLANTED IN A PT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM IN ZONE FOR APPROX ONE MONTH AGO. VESSEL MORPHOLOGY WAS REPORTED AS THE PROXIMAL WAS 22 MM AND DISTALLY IT WAS 18 MM. PRIOR TO THE STENT GRAFT IMPLANTATION THE BILATERAL RENAL ARTERIES AND THE SMA WERE BYPASSED TO THE COMMON ILIAC ARTERY. IT WAS REPORTED THAT THE (B)(4) WAS IMPLANTED FIRST AND IT WAS IMPLANTED DISTALLY VIA THE LEFT FEMORAL ARTERY. A (B)(4) WAS IMPLANTED PROXIMALLY. A TYPE 1 ENDOLEAK WAS SUSPECTED (REF MFR # 2953200-2011-00382). A (B)(4) WAS IMPLANTED PROXIMAL TO THE (B)(4); HOWEVER, THE ENDOLEAK REMAINED. THE PHYSICIAN DECIDED THE ENDOLEAK WAS A TYPE 3 FROM THE SEAM OF THE GRAFT AND IMPLANTED A (B)(4) INSIDE THE (B)(4), BUT THE ENDOLEAK REMAINED. THE PHYSICIAN SUSPECTED A JUNCTIONAL TYPE 3 ENDOLEAK AND A (B)(4) WAS IMPLANTED IN THE JUNCTION AREA OF THE (B)(4) AND (B)(4). TWO WEEKS POST IMPLANTATION THE ENDOLEAK WAS RESOLVED, WITHOUT FURTHER TREATMENT. NO ADD'L CLINICAL SEQUELAE WERE REPORTED, AND THE PT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TALENT THORACIC STENT GRAFT SYSTEM MIH MEDTRONIC CARDIOVASCULAR GALWAY NA V00546225

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention